Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin

Autor: Sangerman M, Moreno A, Quintana A, Garcia-Vidal C, Rubio M, Diaz M, Vendranas M, Macias G

Publikováno v: Expert Review of Hematology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)

Introduction FLT3 inhibitors have been recently introduced as novel treatment targets in patients with FLT3-mutated acute myeloid leukemia (AML). Midostaurin is an oral multikinase inhibitor that targets multiple receptor tyrosine kinases including F

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::99a6563e20503fbb6327f49b7c9157a6
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16521

261 - What is the Outcome of Patients in the Intermediate IPSS-R Score Group? Spanish Approach for Better Stratification with Classical Tools

Autor: Guijo, A.M. Redondo, Sánchez-Barba, M., Santillana, G. Sanz, Bernal, T., Sangerman, M. Arnan, Ortega, F. Ramos, Olivé, C. Pedro, Lozano, M.L. Amigo, Betes, V. Marco, Valcárcel, D., Ardanaz, M., Brunet, S., Lleonart, J. Bargay, Tormo, M., Xicoy, B., Nomdedeu, M., Cadenas, F. López, Berrocal, J.C. Caballero, Cañizo, M.C.D., Díez-Campelo, M.

Publikováno v: In Leukemia Research April 2017 55 Supplement 1:S150-S151

P586: IADADEMSTAT COMBINATION WITH AZACITIDINE SHOWS ENCOURAGING SAFETY AND EFFICACY DATA IN ELDERLY AND UNFIT AML PATIENTS.

Autor: Salamero, O., Somervaille, T., Molero, A., Acuña‐Cruz, E., Perez‐Simon, J. A., Coll, R., Arnan Sangerman, M., Merchan, B., Perez, A., Cano, I., Rodriguez‐Veiga, R., Arevalo, M., Gutierrez, S., Buesa, C., Bosch, F., Montesinos, P.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p485-486, 2p

P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTATED AML. “REAL LIFE” DATA VERSUS THE RATIFY STUDY.

Autor: De La Fuente, A., Diaz Beya, M., Beneit, P., Botella, C., Fernandez Moreno, A., Sampol, A., Arnan Sangerman, M., Yeguas Bermejo, A., Amigo, M. D. L. L., Labrador, J., Garcia Guinon, A., Garrido, A., Serrano, J., Vives Polo, S., Garcia Fortes, M., Sayas, M. J., Bergua, J. M., Olave, M. T., Vall LLovera, F., Bargay, J.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p422-423, 2p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.